Hematopoietic Stem Cell TransplantationTransplantation, HomologousGraft vs Host DiseaseTransplantation ConditioningTissue DonorsStem Cell TransplantationHematopoietic Stem CellsTransplantation, AutologousBone Marrow TransplantationStem CellsPeripheral Blood Stem Cell TransplantationBusulfanWhole-Body IrradiationHematologic NeoplasmsMyeloablative AgonistsGraft SurvivalTransplantation ChimeraBone Marrow CellsVidarabineTreatment OutcomeColony-Forming Units AssayHematopoiesisConditioning, ClassicalCord Blood Stem Cell TransplantationHematopoietic Stem Cell MobilizationCell DifferentiationHistocompatibility TestingLeukemiaMelphalanBone MarrowLiver TransplantationCyclophosphamideImmunosuppressive AgentsConditioning (Psychology)RecurrenceAntigens, CD34Combined Modality TherapySpleenMice, Inbred C57BLHistocompatibilityRemission InductionTime FactorsMultiple MyelomaMesenchymal Stem Cell TransplantationRetrospective StudiesAntilymphocyte SerumGraft vs Tumor EffectRadiation ChimeraT-LymphocytesSurvival AnalysisChimerismCell TransplantationAntineoplastic Combined Chemotherapy ProtocolsKidney TransplantationDisease-Free SurvivalGranulocyte Colony-Stimulating FactorHepatic Veno-Occlusive DiseaseGraft vs Leukemia EffectEmbryonic Stem CellsAnemia, AplasticCells, CulturedSurvival RateGraft RejectionConditioning, EyelidLeukemia, Myeloid, AcuteMyelodysplastic SyndromesGranulocytesFetal BloodSalvage TherapyAdult Stem CellsMice, Inbred StrainsFlow CytometryCell LineageLymphocyte DepletionTransplantation, IsogeneicHematologic DiseasesHLA AntigensBlood Cell CountThymus GlandLymphoma, Non-HodgkinCell SeparationSiblingsPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation ImmunologyClone CellsFollow-Up StudiesCytarabineAcute DiseaseHeart TransplantationUnrelated DonorsCell DivisionImmunosuppressionImmunophenotypingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveEtoposideMice, Inbred C3HMice, Inbred BALB CProto-Oncogene Proteins c-kitPluripotent Stem CellsCyclosporine